Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
Redmile Group LLC | 0 0.000% |
-63,436 (Position Closed) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Cabaletta Bio, Inc. CABA |
Redmile Group LLC | 696,377 2.500% |
-681,942 (-49.48%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | AVITA Medical, Inc. RCEL |
Redmile Group LLC | 672,411 2.700% |
-1,034,975 (-60.62%) |
Filing History |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | HOOKIPA Pharma Inc. HOOK |
Redmile Group LLC | 277,214 9.900% |
11,823 (+4.46%) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 664,817 1.100% |
-3,773,151 (-85.02%) |
Filing History |
| 2022-01-14 5:16 pm Unchanged |
2022-01-10 | 13D | MedAvail Holdings, Inc. MDVL |
Redmile Group LLC | 227,601 34.300% |
0 (Unchanged) |
Filing History |
| 2021-11-29 5:01 pm Sale |
2021-11-29 | 13D | MedAvail Holdings, Inc. MDVL |
Redmile Group LLC | 227,601 34.300% |
-12,992 (-5.40%) |
Filing History |
| 2021-11-01 4:05 pm Purchase |
2021-10-28 | 13D | Augmedix, Inc. AUGX |
Redmile Group LLC | 15,871,125 41.100% |
1,625,000 (+11.41%) |
Filing History |
| 2021-10-18 4:05 pm Purchase |
2021-10-06 | 13D | Science 37 Holdings, Inc. SNCE |
Redmile Group LLC | 990,412 17.300% |
990,412 (New Position) |
Filing History |
| 2021-09-27 4:01 pm Purchase |
2021-09-17 | 13G | GRITSTONE BIO INC GRTSQ |
Redmile Group LLC | 5,729,916 9.900% |
814,187 (+16.56%) |
Filing History |
| 2021-08-02 5:00 pm Purchase |
2021-07-21 | 13D | Absci Corporation ABSI |
Redmile Group LLC | 8,031,094 8.700% |
8,031,094 (New Position) |
Filing History |
| 2021-06-07 4:09 pm Purchase |
2021-05-28 | 13G | Dynamics Special Purpose Corp. DYNS |
Redmile Group LLC | 2,012,900 8.500% |
2,012,900 (New Position) |
Filing History |
| 2021-04-08 4:11 pm Purchase |
2021-03-29 | 13G | LAVA Therapeutics N.V. LVTX |
Redmile Group LLC | 2,824,409 11.100% |
2,824,409 (New Position) |
Filing History |
| 2021-03-02 4:10 pm Purchase |
2021-02-23 | 13G | Ayala Pharmaceuticals, Inc. AYLA |
Redmile Group LLC | 1,381,077 9.990% |
713,261 (+106.81%) |
Filing History |
| 2021-03-01 06:05 am Unchanged |
2021-02-22 | 13D | Augmedix, Inc. AUGX |
Redmile Group LLC | 14,246,125 50.400% |
0 (Unchanged) |
Filing History |
| 2021-02-16 4:27 pm Purchase |
2020-12-31 | 13G | Repare Therapeutics Inc. RPTX |
Redmile Group LLC | 2,647,696 7.200% |
2,647,696 (New Position) |
Filing History |
| 2021-02-16 4:11 pm Purchase |
2020-12-31 | 13G | Itamar Medical Ltd. ITMR |
Redmile Group LLC | 21,345,000 5.000% |
21,345,000 (New Position) |
Filing History |
| 2021-02-16 4:11 pm Sale |
2020-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Redmile Group LLC | 2,397,441 4.900% |
-603,200 (-20.10%) |
Filing History |
| 2021-02-16 4:11 pm Sale |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
Redmile Group LLC | 0 0.000% |
-3,430,529 (Position Closed) |
Filing History |
| 2021-02-16 4:11 pm Purchase |
2020-12-31 | 13G | Replimune Group, Inc. REPL |
Redmile Group LLC | 4,658,043 9.900% |
1,036,408 (+28.62%) |
Filing History |